| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6013657 | PADAGIS US | Pharmaceutical compositions containing mupirocin |
Jul, 2018
(5 years ago) | |
Centany is owned by Padagis Us.
Centany contains Mupirocin.
Centany has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Centany are:
- US6013657
Centany was authorised for market use on 04 December, 2002.
Centany is available in ointment;topical dosage forms.
The generics of Centany are possible to be released after 08 July, 2018.
Drugs and Companies using MUPIROCIN ingredient
Market Authorisation Date: 04 December, 2002
Treatment: NA
Dosage: OINTMENT;TOPICAL
More Information on Dosage
CENTANY family patents
